Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.990
-0.050 (-2.45%)
Apr 23, 2026, 12:03 PM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
Research and Development in The Pharmaceutical Sector | 55.18K | 132.64K | 133.93K | | | |
Research and Development in The Pharmaceutical Sector Growth | -58.40% | -0.96% | - | | | |
| 55.18K | 132.64K | 133.93K | | | |
| -58.40% | -0.96% | - | | | |
Source: S&P Global Market Intelligence.
